Vanda Pharmaceuticals Inc... (VNDA)
NASDAQ: VNDA
· Real-Time Price · USD
4.64
-0.08 (-1.69%)
At close: Sep 04, 2025, 3:59 PM
4.60
-0.86%
After-hours: Sep 04, 2025, 06:01 PM EDT
-1.69% (1D)
| Bid | 3.92 |
| Market Cap | 274.17M |
| Revenue (ttm) | 203.47M |
| Net Income (ttm) | -66.94M |
| EPS (ttm) | -1.14 |
| PE Ratio (ttm) | -4.07 |
| Forward PE | -4.82 |
| Analyst | Strong Buy |
| Ask | 5.27 |
| Volume | 570,296 |
| Avg. Volume (20D) | 476,367 |
| Open | 4.72 |
| Previous Close | 4.72 |
| Day's Range | 4.54 - 4.72 |
| 52-Week Range | 3.81 - 5.55 |
| Beta | 0.72 |
About VNDA
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol VNDA
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for VNDA stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsNext Earnings Release
Vanda Pharmaceuticals Inc. is scheduled to release its earnings on
Nov 5, 2025,
during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
10 months ago
+8.33%
Vanda Pharmaceuticals shares are trading higher af...
Unlock content with
Pro Subscription
1 month ago · seekingalpha.com
Vanda Pharmaceuticals Inc. (VNDA) Q2 2025 Earnings Call TranscriptVanda Pharmaceuticals Inc. (NASDAQ:VNDA ) Q2 2025 Earnings Call July 31, 2025 8:00 AM ET Company Participants Kevin Patrick Moran - Senior VP, CFO & Treasurer Mihael H. Polymeropoulos - Founder, Presi...
